ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia

This study is currently recruiting participants.
Study NCT00450944.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00450944


Locations
United States, New York
Albert Einstein Cancer Center at Albert Einstein College of Medicine     Recruiting
      Bronx, New York, United States, 10461
      Contact: Clinical Trials Office - Albert Einstein Cancer Center at Albe     718-904-2730     aecc@aecom.yu.edu    

Sponsors and Collaborators
Albert Einstein College of Medicine of Yeshiva University

Investigators
Study Chair:     Amit Verma, MD     Albert Einstein College of Medicine of Yeshiva University    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers